Abstract
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the use of topical photodynamic therapy (PDT). The document aims to:
• offer an appraisal of all relevant literature up to April 2018, focusing on any key developments
• address important, practical clinical questions relating to the primary guideline objective and
• provide guideline recommendations and if appropriate research recommendations.
The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and in the clinic, in addition to an updated patient information leaflet [available on the British Association of Dermatologists (BAD) website, www.bad.org.uk/leaflets].
• offer an appraisal of all relevant literature up to April 2018, focusing on any key developments
• address important, practical clinical questions relating to the primary guideline objective and
• provide guideline recommendations and if appropriate research recommendations.
The guideline is presented as a detailed review with highlighted recommendations for practical use in primary care and in the clinic, in addition to an updated patient information leaflet [available on the British Association of Dermatologists (BAD) website, www.bad.org.uk/leaflets].
Original language | English |
---|---|
Pages (from-to) | 730-739 |
Number of pages | 10 |
Journal | British Journal of Dermatology |
Volume | 180 |
Issue number | 4 |
Early online date | 2 Dec 2018 |
DOIs | |
Publication status | Published - Apr 2019 |
Keywords
- GRADE
- systematic review
- 5-aminolaevulinic acid
- methyl aminolaevulinate
- dermatology
- guidelines
- non-melanoma skin cancer
- protoporphyrin IX
- topical photodynamic therapy
ASJC Scopus subject areas
- Dermatology